LFB SA Board of Directors

Composition of the LFB SA Board of Directors, chaired by Denis DELVAL, Chairman and CEO of LFB.

Government commissioner:

Grégory EMERY

Deputy Director-General for Health

French government representative:

Jérémie GUE

Head of the Legal Division at the Government Investments Agency (APE)

Members of the Board appointed by the General Assembly, proposed by French State:

Pascale AUGÉ

Chair of the Executive Board, INSERM TRANSFERT SA

Vincent BERJOT

Head of General Economic and Financial Control – Ministry of Economy and Finance

Corinne FAU

Member of the Board and Chief Financial Officer for Enedis

Loïc ROCARD

CEO of TECHNICATOME

Independent members of the Board appointed by the General Assembly:

Gilles BRISSON

Member of the Supervisory Board of Innate Pharma (SA) and of the Supervisory Board of Financière Verdi III (SAS)

Eric DRAPÉ

Executive VP TEVA PHARMACEUTICALS Ltd , Member of the Board Teva Takeda Pharma Ltd (Japan, SAS)

Members of the Board representing employees:

Claire-Marie BERGUES

Production Manager Arras site – LFB BIOMEDICAMENTS

Vincent DENOIS

Director of Infrastructure and IT Operations, Les Ulis - LFB BIOMEDICAMENTS

Marc LASCOMBES

Project engineer, Lille - LFB BIOMEDICAMENTS

Financial and Economic auditors:

François GUILLON

Auditing PRICEWATERHOUSECOOPERS firm

Laurent BRUN

Cabinet CAILLIAU DEDOUIT and associated

Guests

Maurice-Pierre PLANEL

Government auditor, Général Deputy Director of Health

Marc GAZAVE

Economic and Financial Controller